Literature DB >> 9028448

Increased low-level chromosome 21 mosaicism in older individuals with Down syndrome.

E C Jenkins1, N Schupf, M Genovese, L L Ye, D Kapell, B Canto, M Harris, D Devenny, J H Lee, W T Brown.   

Abstract

During a study of the familial aggregation of Down syndrome (DS) and Alzheimer disease (AD), we observed an increase in mosaicism for disomy 21 in older individuals with DS. In a total of 213 DS subjects who were studied cytogenetically, only 1 of 121 (0.8%) under age 45 exhibited mosaicism, while 14 of 92 (15.2%) who were age 45 or older had mosaicism. Mosaicism in this report connotes "low-level" mosaicism, where all 15 individuals exhibited a modal chromosome number of 47 (i.e., trisomy 21), and at least two cells lacked one of the three chromosomes 21. The occurrence of aneuploidy for chromosomes 15, 17, and X increased with age, and an inverse correlation between chromosome loss and size was also observed. Because older individuals had not been karyotyped at birth, it was not possible to determine whether our observations were due to either increased survival of mosaic individuals or accumulation of disomy 21 cells via increased chromosome loss with aging of the trisomy 21 individual. Using a modeling approach involving life table methods, we obtained results that suggested acquired mosaicism as the predominant mechanism to explain our findings. These results support the hypothesis that as individuals with DS age, there is an increased loss of chromosome 21.

Entities:  

Mesh:

Year:  1997        PMID: 9028448     DOI: 10.1002/(sici)1096-8628(19970120)68:2<147::aid-ajmg5>3.0.co;2-m

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Mechanisms leading to the formation of micronuclei containing sex chromosomes differ with age.

Authors:  Kimberly H Jones; Timothy P York; Colleen Jackson-Cook
Journal:  Mutat Res       Date:  2012-05-18       Impact factor: 2.433

2.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

3.  Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.

Authors:  Eric Doran; David Keator; Elizabeth Head; Michael J Phelan; Ron Kim; Minodora Totoiu; Jorge R Barrio; Gary W Small; Steven G Potkin; Ira T Lott
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Down syndrome, beta-amyloid and neuroimaging.

Authors:  Elizabeth Head; Alex M Helman; David Powell; Frederick A Schmitt
Journal:  Free Radic Biol Med       Date:  2017-09-19       Impact factor: 7.376

5.  The phenotype of persons having mosaicism for trisomy 21/Down syndrome reflects the percentage of trisomic cells present in different tissues.

Authors:  Paulie Papavassiliou; Timothy P York; Nurcan Gursoy; Gloria Hill; Lauren Vanner Nicely; Usha Sundaram; Allison McClain; Steven H Aggen; Lindon Eaves; Brien Riley; Colleen Jackson-Cook
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

6.  Altered DNA methylation in leukocytes with trisomy 21.

Authors:  Kristi Kerkel; Nicole Schupf; Kota Hatta; Deborah Pang; Martha Salas; Alexander Kratz; Mark Minden; Vundavalli Murty; Warren B Zigman; Richard P Mayeux; Edmund C Jenkins; Ali Torkamani; Nicholas J Schork; Wayne Silverman; B Anne Croy; Benjamin Tycko
Journal:  PLoS Genet       Date:  2010-11-18       Impact factor: 5.917

7.  Trisomy correction in Down syndrome induced pluripotent stem cells.

Authors:  Li B Li; Kai-Hsin Chang; Pei-Rong Wang; Roli K Hirata; Thalia Papayannopoulou; David W Russell
Journal:  Cell Stem Cell       Date:  2012-10-18       Impact factor: 24.633

8.  Beyond Trisomy 21: Phenotypic Variability in People with Down Syndrome Explained by Further Chromosome Mis-segregation and Mosaic Aneuploidy.

Authors:  Huntington Potter
Journal:  J Down Syndr Chromosom Abnorm       Date:  2016-03-31

9.  Trisomy 21-associated increases in chromosomal instability are unmasked by comparing isogenic trisomic/disomic leukocytes from people with mosaic Down syndrome.

Authors:  Kelly Rafferty; Kellie J Archer; Kristi Turner; Ruth Brown; Colleen Jackson-Cook
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.